News/ News/ Oncology Roivant joins RNA splicing push with Eisai deal Phil Taylor Eisai, H3 Biomedicine, Oncology, partnering, RNA splicing 0 Comment Roivant is the latest pharma group to take a position in the emerging field of therapies targeted at Share X Roivant joins RNA splicing push with Eisai deal https://pharmaphorum.com/news/roivant-joins-rna-splicing-push-with-eisai-deal/
News/ News/ R&D BMS looks to RNA splicing to boost immunotherapies George Underwood BMS, Bristol-Myers Squibb, immunotherapy, Opdivo, rna, RNA splicing 0 Comment Bristol-Myers Squibb’s quest to claim dominance in the immunotherapy space continues through a new collaboration with Eisai and Share X BMS looks to RNA splicing to boost immunotherapies https://pharmaphorum.com/news/bms-looks-to-rna-splicing-to-boost-immunotherapies/
Eisai, H3 Biomedicine, Oncology, partnering, RNA splicing
0 Comment
